A Delaware Chancery Court ruling last month upheld Airgas, Inc.’s right to employ its shareholders rights plan — a defense known as a “poison pill” — to block an unsolicited offer by Air Products. Don Margotta, associate professor of finance, discusses the resurgence of this corporate defense tactic.
